Efficacy and safety of Shenqi Fuzheng injection in laparoscopic gastric cancer
10.3969/j.issn.1005-1678.2016.06.35
- VernacularTitle:参芪扶正注射液治疗腹腔镜胃癌术后患者的临床疗效及安全性
- Author:
Enting ZHUO
;
Lianchen WANG
;
Xuelian CHEN
;
Guohong FU
;
Songping LIU
- Publication Type:Journal Article
- Keywords:
Shenqi Fuzheng injection;
laparoscopic gastric cancer;
clinical research;
safety
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(6):121-123
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of Shenqi Fuzheng injection in the treatment of patients with laparoscopic gastric cancer. Methods A total of 94 cases with laparoscopic gastric cancer included in this study were divided into control group and experimental group with 47 cases in each group.The patients in both groups received laparoscopic gastric carcinoma.Patients in control group received fluorouracil, leucovorin and oxaliplatin infusion( FOLFOX4 ) chemotherapy and patients in the experimental group revieved Shenqi Fuzheng injection.Both groups received two courses treatment of 14 days for one course.The clinical efficacy, inflammatory levels, tumor indicators and adverse drug reactions were compared between the two groups.Results The clinical efficacy in experimental group was 95.74%, which was significantly higher than that in control group 82.98%(P<0.05 ) .The serum level of serum serum albumin (ALB), prealbumin (PA), glutathione-S-transferase (GST), carcinoembryonic antigen (CEA) and carbohydrate antigen 199 (CA199) after treatment in experimental group were lower than the control group (P<0.05) .The adverse drug reactions was not statistically different between the two groups.Conclusion Shenqi Fuzheng injection has significant efficacy in the treatment of laparoscopic gastric cancer with high safety.
